At Invetus, we recognize the substantial time and cost involved in advancing investigational molecules to the first human clinical trials. Our commitment is to support you by streamlining this process, reducing costs, and saving time through our world-class research capabilities, potentially coupled with attractive tax incentives.
How We Assist You: We offer an array of preclinical studies using various animal models. This not only cuts down on time and expenses but also provides an initial assessment of therapeutic safety.
Preclinical Studies with Animal Models: At Invetus, our focus is on providing the most relevant in vivo models using different animal species. We aim to facilitate the validation and registration of your new therapeutic product in an economically straightforward manner.
Key Animal Models
Laboratory Animal Models (mice, rats, guinea pigs, rabbits): These models play a crucial role in biomedical research due to their anatomical and physiological resemblance to humans.
Large Animal Models (pigs, sheep, dogs, cats, horses): Offering unique physiological and anatomical characteristics, these models share many diseases with humans. They are instrumental in demonstrating the safety and effectiveness of human medicine, biologics, or devices.
-
• Drug Metabolism and Pharmacokinetics
• Bioequivalence and Bioavailability Studies
• Safety Assessments
• ADME
• Immunogenicity Testing
• Screening and Preliminary Toxicology
• Acute and Dose Range Finding
• Repeat-dose Toxicology
-
• Cardiology (Pigs, Sheep, and Dogs)
• Osteoarthritis (Dogs)
• Inflammation/Metabolic (Dogs, Cats, Sheep, and Pigs)
• Pharmacokinetics/Pharmacodynamics (Dogs)
• Implants/Scaffolds/Regenerative Medicine (Dogs, Pigs, and Sheep)
• Orthopaedics (Dogs, Sheep, and Pigs)
• Dermatology (Pigs and Dogs)
• Pain Management (Dogs, Sheep, Horses)
• Comparative Oncology (Dogs and Cats) e.g. Lymphoma, Osteosarcoma, Glioblastoma, Meningioma, Melanoma, Mammary, Solid Tumours, Haemangiosarcoma, Nasal Carcinoma
